Previous studies have shown that in vivo inhibition of WNT-5A attenuated tissue destruction, improved lung function and restoration of alveolar epithelial cell markers expression in two animal models of COPD [24, 34]. This evidence concerns the gene WNT5A and chronic obstructive pulmonary disease.